home / stock / iart / iart articles

IART Articles, Integra LifeSciences Holdings Corporation - From 02/28/24

Stock Information
Company Name: Integra LifeSciences Holdings Corporation
Stock Symbol: IART
Market: NASDAQ
Website: integralife.com
Menu
IART IART Quote IART Short IART News IART Articles IART Message Board
Get IART Alerts

News, Short Squeeze, Breakout and More Instantly...
Integra LifeSciences Announces Leadership Transition Plan | Benzinga

Jan De Witte to retire as CEO by the end of 2024Stuart Essig appointed executive chairman of the Board PRINCETON, N.J., Feb. 28, 2024 (GLOBE NEW...
INVESTIGATION ALERT: Kaskela Law LLC Announces Shareholder Investigation of Integra LifeSciences Holdings Corp. (NASDAQ: IART) and Encourages Long-Term Investors to Contact the Firm | Benzinga

PHILADELPHIA, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it has commenced an investigation into Integra LifeSciences Holdi...

Integra LifeSciences to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on February 28, 2024 | Benzinga

PRINCETON, N.J., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology...

Integra LifeSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference | Benzinga

PRINCETON, N.J., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology...
INTEGRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Integra LifeSciences Holdings Corp. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm | Benzinga

NEW YORK, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigati...

Neurosurgery Focused Integra LifeSciences Bolsters Its ENT Portfolio With $275M Acquisition Deal | Benzinga

Integra LifeSciences Holdings Corporation (NASDAQ: IART) agreed to acquire Acclarent Inc. from Ethicon Inc, a Johnson & Joh...

Integra LifeSciences Announces Definitive Agreement to Acquire Acclarent® | Benzinga

The acquisition will become part of Integra's Codman Specialty Surgical (CSS) division. The ear, nose and throat (ENT) category is a key are...
Integra LifeSciences Appoints Jeff Graves, Ph.D., to Board of Directors | Benzinga

PRINCETON, N.J., Dec. 12, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology...

Block To Rally Around 54%? Here Are 10 Top Analyst Forecasts For Tuesday | Benzinga

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...

DEADLINE ALERT for DOCN, IART, and EVA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders | Benzinga

LOS ANGELES, Nov. 13, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on ...
Previous 10 Next 10